SCHEMBL26742006

SCHEMBL26742006

CC(C)OCCN1CCN(CC(=O)N2CCN(C(C)C)CC2)CC1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.41
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ALDH1A1 P00352 3/20 0.38
PKM P14618 2/20 0.38
KDM4E B2RXH2 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
SIGMAR1 Q99720 1/20 0.37
LMNA P02545 2/20 0.37
SLC6A4 P31645 2/20 0.36
SLC6A3 Q01959 2/20 0.36
DRD3 P35462 1/20 0.36
MAPT P10636 1/20 0.36
HRH3 Q9Y5N1 3/20 0.36
TP53 P04637 1/20 0.34
RECQL P46063 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26742004 0.92 GAA (0.39) GAAALOX15TSHRHSD17B10ALDH1A1
SCHEMBL29330497 0.87 HSD11B1 (0.45) GAAALOX15TSHRHSD17B10ALDH1A1
SCHEMBL26746316 0.87 GAA (0.42) GAAALOX15TSHRHSD17B10ALDH1A1
SCHEMBL13004984 0.84 GAA (0.55) GAAALOX15TSHRHSD17B10ALDH1A1
SCHEMBL12448058 0.83 DAO (0.39) SIGMAR1DRD3HRH3
SCHEMBL26706125 0.82 KDM4E (0.34) ALDH1A1KDM4EL3MBTL1LMNAHRH3
SCHEMBL29330505 0.82 GAA (0.40) GAAALOX15TSHRHSD17B10ALDH1A1
SCHEMBL18704941 0.82 GAA (0.48) GAAALOX15TSHRHSD17B10ALDH1A1
SCHEMBL26706123 0.81 HRH3 (0.39) GAAALOX15TSHRHSD17B10ALDH1A1
SCHEMBL29342204 0.81 KDM4E (0.43) GAAALOX15ALDH1A1PKMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240238423-A9 TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS Treeline Biosciences, Inc. 2024-07-18 US disclosed
US-20240238423-A9 TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS Treeline Biosciences, Inc. 2024-07-18 US disclosed
WO-2023215482-A1 TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS Treeline Biosciences, Inc. (US) 2023-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240238423-A9 TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS BCL2A1, BCL2L1, BCL3 GAA 597/4885ALOX15 3872/4885TSHR 4074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.